Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari


Expert presentations and opinions on REZZAYO® rezafungin


Watch or listen to expert presentations and opinions on REZZAYO®, and access dedicated learning resources or materials for your patients

Interested in learning more about how REZZAYO® could help in your hospital?
Request an appointment with a Napp representative


Mechanism of action (MOA)

Discover the benefits of REZZAYO® mechanism of action



REZZAYO® rezafungin budget impact summary

REZZAYO® rezafungin budget impact summary

Calculate any potential cost saving that could be achieved by switching your patients from their current treatment.


    Adverse events should be reported. Reporting forms and information can be found at

    Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or

    ®: REZZAYO is a Registered Trademark of Cidara Therapeutics, Inc., used under license